EQUITAS
LIVE

Serial Number

86848934

Owner

B D Forrest & Company, Inc.

First Use Date

Apr 16, 2015

Filing Date

Dec 14, 2015

Add to watchlist:

No watchlists yet
View on USPTO

EQUITAS Trademark

Serial Number: 86848934 • Registration: 5007758

EQUITAS is a trademark filed by B D Forrest & Company, Inc. on December 14, 2015. The trademark is classified under Class 42 (Computer & Scientific), Class 45 (Legal & Security Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

B D Forrest & Company, Inc. (5 trademarks)

135 Piermont Avenue
South Nyack, NY 109604513

Entity Type: 03

HUDSON INNOVATIONS, LLC (3 trademarks)

PO BOX 444
NYACK, NY 10960

Entity Type: 16

Equitas Bio/Pharma Solutions, LLC (2 trademarks)

4111 W. Inman Avenue
Tampa, FL 33609

Entity Type: 16

Trademark Details

Filing Date

December 14, 2015

Registration Date

July 26, 2016

First Use Anywhere

April 16, 2015

First Use in Commerce

April 22, 2015

Published for Opposition

May 10, 2016

Goods & Services

Pharmaceutical and biopharmaceutical business plan development; business consultation services in the field of pharmaceutical and biopharmaceutical regulatory strategy; business consultation in the field of pharmaceutical and biopharmaceutical foreign market entry; business management services in the field of pharmaceutical and biopharmaceutical products and medical devices; business development and commercial administration of the licensing of pharmaceutical and biopharmaceutical products and medical devices; Providing advertising, marketing and promotional services for pharmaceutical and biopharmaceutical products and medical devices; marketing plan development for pharmaceutical and biopharmaceutical products and medical devices; market research and business analyses and advice for pharmaceutical and biopharmaceutical products and medical devices

Consulting in the field of pharmaceutical and biopharmaceutical regulations with regard to regulatory strategy

Consulting services, namely, pharmaceutical and biopharmaceutical product development; pharmaceutical and biopharmaceutical clinical development and product testing; research and development of pharmaceutical and biopharmaceutical products and medical devices

Filing History

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Jul 26, 2025 REM2
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Aug 25, 2022 NAS8
REGISTERED - SEC. 8 (6-YR) ACCEPTED
Aug 25, 2022 8.OK
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Aug 2, 2022 APRE
TEAS SECTION 8 RECEIVED
Mar 9, 2022 ES8R
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Jul 26, 2021 REM1
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Sep 24, 2020 ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Aug 15, 2018 ASGN
REGISTERED-PRINCIPAL REGISTER
Jul 26, 2016 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 10, 2016 NPUB
PUBLISHED FOR OPPOSITION
May 10, 2016 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 20, 2016 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 29, 2016 CNSA
ASSIGNED TO EXAMINER
Mar 29, 2016 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 19, 2015 NWOS
NEW APPLICATION ENTERED
Dec 17, 2015 NWAP